IND submission is a major milestone in the life of your drug. We can provide all supporting analytical data to help ensure a smooth application process.
We have the expertise, flexibility, and resources to provide a full range of pharmaceutical API custom development services at every stage of the lifecycle.
We can provide lab-, kilo- and pilot-scale manufacturing for preclinical studies and all phases of clinical trials, supplying milligram to kilogram quantities.
Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical partners. From our sites in Italy, Sweden, and the USA, we are a leading global supplier of generic APIs.
Drug substance tech transfer sounds so simple on the surface, but it’s a complex activity carrying a number of technical, regulatory, and quality risks.
At Snapdragon Chemistry, now part of Cambrex, our chemists specialize in creating custom solutions and technologies to take on your toughest process development and production challenges. This includes expertise in designing and building reactors that enable seamless technology transfer as a process scales up for commercial manufacturing.
At Cambrex, we provide a range of technologies equipped to solve your API manufacturing challenges, and we are flexible enough to handle the most complex molecules.
You can rely on our extensive portfolio of analytical development solutions and testing services to rapidly advance your molecule for the greatest chance of success.
We’re solid state chemistry experts who can deliver timely, phase-appropriate solutions to optimize the physical stability of your API, develop a more bioavailable formulation or overcome other challenges.
Cambrex’s experienced analysts are well-equipped to ensure microbial testing is of the highest quality for our customers and delivered with a quick and reliable turnaround.
Cambrex and Q1 Scientific’s stability storage and sample management capabilities provide a variety of pharmaceutical storage conditions, with walk-in and reach-in chambers that meet all ICH Q1A requirements.
Cambrex offers extensive development services tailored to meet your drug product needs in early development. From pre-formulation to Phase II, we ensure your products are developed with speed, flexibility, and quality in mind.
Whether you need rapid development, flexible manufacturing solutions, or high-quality production, Cambrex is your trusted partner for advancing your drug product from concept to the clinic.
Cambrex is here to support you in early-phase development. Our development experts apply their ingenuity and skill to address your unique challenges.
Our teams of creative problem-solvers work closely with you to accelerate drug development timelines, optimize processes, and meet regulatory requirements.
We understand that the commercial phase of drug development can be challenging, especially when it comes to manufacturing at scale and meeting changing market demands.
Cambrex is a leading global supplier of more than 70 generic APIs, as well as intermediates and derivatives.
When you need a trusted partner to help advance your molecule through development and testing, you can count on Cambrex to help you find the most efficient path to a high-quality solution. Our analytical services encompass best-in-class chromatographic, spectroscopic and mass spectrometric solutions, enabling us to deliver rapid method development for small molecules and complex synthetics.
When you need a partner to overcome challenging test methods — or challenging molecules — you can rely on the Cambrex team. Our customers appreciate our partnership, our expertise, our specialized services and our flexibility to solve complex problems as they navigate regulatory requirements. We offer a broad range of analytical testing services that extend across every phase of drug development.
We offer extensive solid state screening, as a standalone service or as part of a comprehensive drug development program, to help your team understand and characterize the physical properties of your active pharmaceutical ingredient (API). Our specialists provide testing for a range of physical and chemical properties and deliver timely, phase-appropriate solutions.
Our extensive microbiology testing services, delivered at our FDA-registered and GMP-compliant labs, address customer needs for API and drug product safety at every phase of development. Our experienced analysts provide personalized attention, ensuring that your project receives high-quality and timely results to assess microbiological safety.
Cambrex offers state-of-the-art, environmentally-controlled and monitored facilities to meet all ICH Q1A guidelines. We have dedicated stability rooms and chambers validated for long- and short-term shelf-life studies, making it possible to evaluate the quality of your API and drug product over time when exposed to different temperature and humidity conditions.
Our streamlined IND data collection and submission strategy, based on our decades of experience, helps accelerate your filing process without sacrificing quality.
We offer comprehensive analytical testing services to provide the data you need for critical early-phase drug development decisions. At our state-of-the-art facilities, Cambrex experts ensure regulatory compliance and the highest standards for safety and efficacy.
Our development experts specialize in using creative problem-solving to handle early-phase challenges while maintaining validation rigor to avoid late-stage process changes. This helps you advance more rapidly to late-stage manufacturing.
With decades of experience and broad capabilities, our flexible manufacturing and packaging solutions can support changing demands to meet your late-phase clinical trial needs.
By offering a comprehensive suite of analytical testing services, we can support your late-phase development and ensure your clinical trial materials meet the highest standards for safety and quality.
At Cambrex, our experts specialize in API manufacturing and scale-up from preclinical to commercial phases. We offer extensive manufacturing capabilities, streamlined technology transfer, and consistent support across all sites.
Although every technology transfer process is different, our experts apply their skills and knowledge to make the transition to commercial manufacturing as smooth as possible.
Cambrex is a leading global supplier of generic APIs with sites in Italy, Sweden, and the US. We collaborate with generic drug firms before patent expiration and offer comprehensive services and manufacturing capabilities.
Our global manufacturing facilities reliably supply high-quality advanced pharmaceutical intermediates and raw starting materials. We maintain a large catalog of APIs and have a proven track record for meeting cGMP standards.
Pharmaceutical and biotech companies often face a pivotal decision: should they manage certain operations internally or partner with a trusted external provider? In this webinar, we explain how outsourcing stability storage and testing offers a strategic advantage, enabling pharmaceutical and medical device companies to optimize their stability programs and stay competitive in the global market.
In our latest whitepaper, we dive deeper into the strategic benefits of outsourcing stability storage, provide you with a comprehensive guide on how to select the right partner for your needs, and highlight case studies that showcase real-world examples of pharmaceutical companies that have successfully outsourced stability storage and reaped the benefits.
Performing stability storage in-house can entail significant costs and risks for pharmaceutical and medical device companies, including capital and operational expenditures, compliance risks, and opportunity costs due to capacity constraints. In our recent infographic, we highlight the various costs and risks associated with in-house stability storage.
We love challenges, and we would like to learn more about yours. Contact us to discuss your project.